In another study, the AI-based evaluation of Ki-67 in breast cancer was performed using a workflow based on the Inception v3 and ResNet architectures, and the findings were compared with the Ki-67 standard reference card assessment, with the authors reporting an intra-group correlation coefficient larger than 0.905 among the pathologists that used these two methods [28]. Here, MKI67 is linked to breast carcinoma.